Summary:
A Randomized, Double-Blind, Placebo-Controlled Monotherapy Trial to Evaluate the Efficacy and Safety of ENX-102 in Patients with Generalized Anxiety Disorder
Qualified Participants Must:
Be 18 - 65 years old
Be diagnosed with Generalized Anxiety Disorder (GAD)
Additional criteria apply
Qualified Participants May Receive:
Up to $1,249 for time and travel